Literature DB >> 21485675

Analysis of human cultured myotubes responses mediated by ryanodine receptor 1.

M Kobayashi1, K Mukaida, T Migita, H Hamada, M Kawamoto, O Yuge.   

Abstract

Malignant hyperthermia is a life-threatening condition caused by autosomal dominant mutations in the ryanodine receptor type 1 gene. Identifying patients predisposed to malignant hyperthermia is done through the Ca-induced Ca release test in Japan. We examined the intracellular calcium concentration in human cultured muscle cells and compared the sensitivity of myotubes to ryanodine receptor type 1 activators based on the Ca-induced Ca release rate. We assessed the utility of this method as an identifying test for predisposition to malignant hyperthermia. Muscle specimens were obtained from 34 individuals undergoing the Ca-induced Ca release test. We cultured myotubes from residual material and monitored changes in intracellular calcium concentration after exposure to the ryanodine receptor type 1 activators caffeine, halothane and 4-chloro-m-cresol by measuring fura-2 fluorescence. We determined the half maximal effective concentrations (EC50) for the test compounds in each myotube and calculated cut-off points using receiver operating characteristic curves. Seventeen patients each were classified into the accelerated and non-accelerated groups based on their Ca-induced Ca release rate. The EC50 values for caffeine, halothane and 4-chloro-m-cresol of the accelerated group were significant lower than those of the non-accelerated group (P < 0.001, P < 0.001 and P < 0.001, respectively). The calculated cut-off points of EC50 values for caffeine, halothane and 4-CmC were 3.62 mM, 2.28 mM and 197 microM, respectively. An increased sensitivity to ryanodine receptor type 1 activators was seen in myotubes in the accelerated group. This functional test on human cultured myotubes indicates that the alteration of their intracellular Ca2+ homeostasis may identify the predisposition to malignant hyperthermia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21485675     DOI: 10.1177/0310057X1103900216

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  3 in total

1.  Myotoxicity of local anesthetics is equivalent in individuals with and without predisposition to malignant hyperthermia.

Authors:  Sachiko Otsuki; Toshimichi Yasuda; Keiko Mukaida; Yuko Noda; Rieko Kanzaki; Hirotsugu Miyoshi; Takashi Kondo; Hiroshi Hamada; Masashi Kawamoto
Journal:  J Anesth       Date:  2018-06-25       Impact factor: 2.078

2.  Genetic and functional analysis of the RYR1 mutation p.Thr84Met revealed a susceptibility to malignant hyperthermia.

Authors:  Takashi Kondo; Toshimichi Yasuda; Keiko Mukaida; Sachiko Otsuki; Rieko Kanzaki; Hirotsugu Miyoshi; Hiroshi Hamada; Ichizo Nishino; Masashi Kawamoto
Journal:  J Anesth       Date:  2018-01-17       Impact factor: 2.078

Review 3.  Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.

Authors:  Tokunbor A Lawal; Emily S Wires; Nancy L Terry; James J Dowling; Joshua J Todd
Journal:  Orphanet J Rare Dis       Date:  2020-05-07       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.